Back
Vistagen Therapeutics Faces Investor Class Action Lawsuit
Back
Stock News
Themes
Vistagen Therapeutics Faces Investor Class Action Lawsuit
Vistagen Therapeutics Faces Investor Class Action Lawsuit
Edgen Stock
·
Jan 21 2026, 03:54
Share to
Share to
Copy link
VTGN
-0.81%
source:
[1] ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Vistagen Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTGN
Recommend
Regentis Reports Breakthrough Cartilage Regeneration in 2-Year GelrinC Study
Jan 20 2026, 14:36
ServiceNow Taps OpenAI to Embed AI Agents in Enterprise Software
Jan 20 2026, 14:32
Bristol Myers Taps Microsoft AI for Lung Cancer Detection
Jan 20 2026, 14:26
Edgen Stock·Jan 21 2026, 03:54Edgen Stock·Jan 21 2026, 03:54
Edgen Stock·Jan 21 2026, 03:54